Our data suggest that impairment of CXCR-4 expression in EPCs and reduction of number of Sca1+/c-kit+ stem cell in infarcted area may be responsible for impairment of cardiac repair in Sirt3KO-BMC treatment in post-MI mice. This evidence concerns the gene CXCR4 and myocardial infarction.